Search

A study conducted in Okayama, Japan, focused on a 70-year-old woman with anti-aminoacyl-tRNA synthetase (ARS) antibody-positive interstitial lung disease (ARS-ILD) who developed secondary pulmonary alveolar proteinosis (PAP) during treatment. Despite intensified immunosuppressive therapy, the patient's condition worsened, leading to a diagnosis of PAP. The research was peer-reviewed and published in Internal Medicine, providing valuable insights into the development of PAP in patients with ARS-ILD. [Extracted from the article]

An interview with architect Emilio Ambasz is presented. Topics include considered that the institute is a separate entity freshman in the School of Architecture, but to a few professors, mainly Peter Eisenman, was moved from freshman to senior in the first semester; and focuses on a Luis Barragán exhibition.

Keywords: Okayama; Japan; Asia; Autoimmune Diseases and Conditions; Autoimmune Diseases and Conditions of the Nervous System; Cancer; Diseases and Conditions; Drugs and Therapies; Health and Medicine; Immune System Diseases and Conditions; Immunologic Agents; Immunotherapy; Lambert-Eaton Myasthenic Syndrome; Lung Cancer; Lung Diseases and Conditions; Lung Neoplasms; Monoclonal Antibodies; Myasthenic Syndrome; Nervous System Paraneoplastic Syndromes; Neurodegenerative Diseases and Conditions; Non-Small Cell Lung Cancer; Oncology; Pembrolizumab Therapy; Pharmaceuticals EN Okayama Japan Asia Autoimmune Diseases and Conditions Autoimmune Diseases and Conditions of the Nervous System Cancer Diseases and Conditions Drugs and Therapies Health and Medicine Immune System Diseases and Conditions Immunologic Agents Immunotherapy Lambert-Eaton Myasthenic Syndrome Lung Cancer Lung Diseases and Conditions Lung Neoplasms Monoclonal Antibodies Myasthenic Syndrome Nervous System Paraneoplastic Syndromes Neurodegenerative Diseases and Conditions Non-Small Cell Lung Cancer Oncology Pembrolizumab Therapy Pharmaceuticals 228 228 1 05/08/23 20230509 NES 230509 2023 MAY 9 (NewsRx) -- By a News Reporter-Staff News Editor at Immunotherapy Weekly -- Research findings on Oncology - Non-Small Cell Lung Cancer are discussed in a new report. Okayama, Japan, Asia, Autoimmune Diseases and Conditions, Autoimmune Diseases and Conditions of the Nervous System, Cancer, Diseases and Conditions, Drugs and Therapies, Health and Medicine, Immune System Diseases and Conditions, Immunologic Agents, Immunotherapy, Lambert-Eaton Myasthenic Syndrome, Lung Cancer, Lung Diseases and Conditions, Lung Neoplasms, Monoclonal Antibodies, Myasthenic Syndrome, Neurodegenerative Diseases and Conditions, Non-Small Cell Lung Cancer, Oncology, Pembrolizumab Therapy, Pharmaceuticals, Nervous System Paraneoplastic Syndromes. [Extracted from the article]

An interview with Emilio Ambasz , an award winning green architect and designer, is presented. When asked regarding his most important work, he refers to La Casa de Retiro Espiritual or the House of Cordoba in Cordoba, Spain. He says that any architectural project not trying to propose new or better modes of existence is unethical. He lays claim to being the precursor of the existing architectural production with consideration of environmental problems.